ISSN 1073-1105 (Print); ISSN 1748-720X (Online)
INTRODUCTION: The Challenge of Developing Oversight Approaches to Nanobiotechnology
Paradise, Jordan; Wolf, Susan M.; Kuzma, Jennifer; Ramachandran, Gurumurthy; Kokkoli, Efrosini
Evaluating Oversight Systems for Emerging Technologies: A Case Study of Genetically Engineered Organisms
Kuzma, Jennifer; Najmaie, Pouya; Larson, Joel
Commentary: Emerging Technologies Oversight: Research, Regulation, and Commercialization
Commentary: Is It Possible to Determine the Extent to Which Informational Asymmetries and Prejudice Bias Responses?
Evaluating Oversight of Human Drugs and Medical Devices: A Case Study of the FDA and Implications for Nanobiotechnology
Paradise, Jordan; Tisdale, Alison W.; Hall, Ralph F.; Kokkoli, Efrosini
Commentary: Public Outreach by the FDA: Evaluating Oversight of Human Drugs and Medical Devices
Frankel, Mark S.
Commentary: Evaluating Oversight of Human Drugs and Medical Devices
Foote, Susan Bartlett
Review of the OSHA Framework for Oversight of Occupational Environments
Choi, Jae-Young; Ramachandran, Gurumurthy
Commentary: Oversight of Engineered Nanomaterials in the Workplace
Maynard, Andrew D.
Gene Therapy Oversight: Lessons for Nanobiotechnology
Wolf, Susan M.; Gupta, Rishi; Kohlhepp, Peter
Commentary: Who's Afraid of the RAC? Lessons from the Oversight of Controversial Science
Kahn, Jeffrey P.
Developing U.S. Oversight Strategies for Nanobiotechnology: Learning from Past Oversight Experiences
Paradise, Jordan; Wolf, Susan M.; Kuzma, Jennifer; Kuzhabekova, Aliya; Tisdale, Alison W.; Kokkoli, Efrosini; Ramachandran, Gurumurthy
Governance of Nanotechnology and Nanomaterials: Principles, Regulation, and Renegotiating the Social Contract
Kimbrell, George A.
What Does the History of Technology Regulation Teach Us about Nano Oversight?
Marchant, Gary E.; Sylvester, Douglas J.; Abbott, Kenneth W.
Problem Formulation and Option Assessment (PFOA) Linking Governance and Environmental Risk Assessment for Technologies: A Methodology for Problem Analysis of Nanotechnologies and Genetically Engineered Organisms
Nelson, Kristen C.; Andow, David A.; Banker, Michael J.
Science, Ethics, and the “Problems” of Governing Nanotechnologies
Hogle, Linda F.
Risk Communication for Nanobiotechnology: To Whom, About What, and Why?
Priest, Susanna Hornig
Using Expert Elicitation to Prioritize Resource Allocation for Risk Identification for Nanosilver
Fauss, Emma; Gorman, Michael E.; Swami, Nathan
Combining Instrumental and Contextual Approaches: Nanotechnology and Sustainable Development
INTRODUCTION: Comparative Health Law and Policy: What, If Anything, Can We Learn from Other Countries?
Why Patients Sue Doctors: The Japanese Experience
Feldman, Eric A.
Between Public Opinion and Public Policy: Human Embryonic Stem-Cell Research and Path-Dependency
Latham, Stephen R.
Realization of the International Human Right to Health in an Economically Integrated North America
Kinney, Eleanor D.
Tobacco Industry Use of Corporate Social Responsibility Tactics as a Sword and a Shield on Secondhand Smoke Issues
Friedman, Lissy C.
Ethical and Legal Analyses of Policy Prohibiting Tobacco Smoking in Enclosed Public Spaces
Oriola, Taiwo A.
Opioid Contracts and Random Drug Testing for People with Chronic Pain — Think Twice
Currents in Contemporary Ethics: The Role of Parents in Expanded Newborn Screening
Teaching Health Law: Combining Pedagogy and Practice: Creating A 21st Century Health Law Curriculum
Singer, Lawrence E.; Bess, Megan
Reviews in Health Law: An Examination of the Power of Narrative: A Review of Health Law and Bioethics: Cases in Context
Coughlin, Christine Nero